Meiyu Jin
Overview
Explore the profile of Meiyu Jin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin M, Mengfan L, Yu H, Cheng J, Zhang Y, Zhai Y, et al.
Mol Immunol
. 2025 Feb;
180:33-43.
PMID: 39999524
Acute hepatitis, characterized by rapid onset and high mortality, can result from infections, toxins, and other factors. However, current treatment options have significant side effects, necessitating further research into alternative...
2.
Zou M, Han Y, Jin M, Xie W, Shang C, Li T, et al.
Autism
. 2025 Jan;
:13623613241311736.
PMID: 39763095
Policies have been found to play a crucial role in supporting the health and well-being of individuals with autism. Yet, relatively few policy reviews are related to autism, and the...
3.
Luo J, Lin M, Chen M, Chen J, Zhou X, Liu K, et al.
Transl Oncol
. 2024 Nov;
51:102180.
PMID: 39536695
Background: Natural killer cells, interconnected with patient prognosis and treatment response, play a pivotal role in the tumor immune microenvironment and may serve as potential novel predictive biomarkers for renal...
4.
Wang Q, Wei Y, Wang Y, Yu Z, Qin H, Zhao L, et al.
Biochim Biophys Acta Mol Cell Biol Lipids
. 2024 Apr;
1869(5):159497.
PMID: 38649009
Backgrounds: Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases. The leaves of Broussonetia papyrifera contain a large number of flavonoids, which have a variety...
5.
Lin H, Fu L, Zhou X, Yu A, Chen Y, Liao W, et al.
Cancer Lett
. 2024 Mar;
593:216807.
PMID: 38462037
The tumour microenvironment (TME) drives bladder cancer (BLCA) progression. Targeting the TME has emerged as a promising strategy for BLCA treatment in recent years. Furthermore, checkpoint blockade therapies are only...
6.
Jin M, Hurley L, Xu H
Bioorg Med Chem Lett
. 2023 Jun;
91:129384.
PMID: 37339720
DNA G-quadruplex (G4) structures are enriched at human genome loci critical for cancer development, such as in oncogene promoters, telomeres, and rDNA. Medicinal chemistry approaches to developing drugs that target...
7.
Yu H, Yan S, Jin M, Wei Y, Zhao L, Cheng J, et al.
Phytomedicine
. 2023 Mar;
113:154746.
PMID: 36905866
Background: Non-alcoholic fatty liver disease (NAFLD) is a common metabolic liver disease worldwide. It has been proven that aescin (Aes), a bioactive compound derived from the ripe dried fruit of...
8.
Wei Y, Tan W, Qin H, Jin M, Yu H, Cheng J, et al.
Mol Biol Rep
. 2022 Oct;
50(1):97-106.
PMID: 36308582
Background: Carbon tetrachloride (CCl) is highly toxic to animal liver and is a major contributor to liver injury. Gomphrena globosa L. (GgL) is an edible plant with anti-inflammation and antioxidation...
9.
Zhao L, Zheng L, Li Z, Jin M, Wang Q, Cheng J, et al.
Aging (Albany NY)
. 2022 Sep;
14(17):6993-7002.
PMID: 36057264
Overdose of acetaminophen (APAP) is currently one of the main causes of hepatoxicity and acute liver injury, which is often linked to oxidative stress. Phellinus linteus polysaccharides (Phps) have shown...
10.
Jin M, Zheng L, Wei Y, Cheng J, Zhang D, Yan S, et al.
Environ Toxicol Pharmacol
. 2022 Jan;
90:103819.
PMID: 35077907
It is well known that gut microbiota imbalance can promote the development of metabolic disease. Enterobacter cloacae (E. cloacae) is a kind of opportunistic pathogen in the intestine. Therefore, we...